Compounds derived from oxindoles and their therapeutic application in cancer treatment
AssigneeAventis Pharma S. A.
InventorsCecile Combeau, Patrick Mailliet, Marielle Chiron
Life of this patent
Estimating the term…
Abstract
The invention relates to compounds of formula (I) 1 in which R5 is chosen from the group consisting of: 2 in which R2 is a C1-C3 alkyl group in which X may be Cl, Br, or F in which n is between 1 and 3, in the E or Z form, or a mixture of the two isomeric forms, possessing antimitotic, antiproliferative and antivascular properties through inhibition of the polymerization of tubulin into microtubules.
Claims15
A compound of formula (I)
- 21
- wherein:
- R5 is selected from the group consisting of:
- 22
- R2 is C1-C3 alkyl;
- X is Cl, Br, or F;
- and
- n is between 1 and 3, in the E or Z form, or a mixture of the two isomeric forms.
15 A method for the treatment of primary tumors of cancer comprising administering to a patient in need of said treatment a therapeutically effective antivascular amount of a compound according to claim 1.
Dependencies are inferred from the claim text.